CORCEPT THERAPEUTICS INC Annual Costs and Expenses in USD from 2013 to 2023

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Corcept Therapeutics Inc quarterly/annual Costs and Expenses history and growth rate from 2013 to 2023.
  • Corcept Therapeutics Inc Costs and Expenses for the quarter ending June 30, 2024 was $128M, a 45.5% increase year-over-year.
  • Corcept Therapeutics Inc Costs and Expenses for the twelve months ending June 30, 2024 was $442M, a 34.1% increase year-over-year.
  • Corcept Therapeutics Inc annual Costs and Expenses for 2023 was $375M, a 29.7% increase from 2022.
  • Corcept Therapeutics Inc annual Costs and Expenses for 2022 was $289M, a 19.8% increase from 2021.
  • Corcept Therapeutics Inc annual Costs and Expenses for 2021 was $242M, a 7.01% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $375M +$85.9M +29.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-15
2022 $289M +$47.7M +19.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-15
2021 $242M +$15.8M +7.01% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-15
2020 $226M +$30.8M +15.8% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $195M +$33.1M +20.5% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-15
2018 $162M +$55.4M +52.1% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-23
2017 $106M +$35.2M +49.5% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-24
2016 $71.1M +$17.4M +32.4% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-26
2015 $53.7M -$441K -0.81% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-28
2014 $54.2M +$2.32M +4.47% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-06
2013 $51.9M Jan 1, 2013 Dec 31, 2013 10-K 2016-03-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.